This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Coronary Artery Disease Hospital Myocardial Infarction 
Cardiology Update
MARCH 5, 2024
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. years, with 57.1% occurring within 30 days after CABG. Original article: Redfors B et al.
Med Page Today
JUNE 26, 2024
(MedPage Today) -- Influenza infection was associated with an increased risk of acute myocardial infarction (MI), especially for those without a prior hospitalization for coronary artery disease (CAD), according to a Dutch observational case series.
143 
Cardiology Update
MARCH 4, 2024
The optimal surveillance strategy after percutaneous coronary intervention (PCI) for high-risk patients with multivessel or left main coronary artery disease (CAD) remains uncertain. The primary outcome was a composite of death from any cause, myocardial infarction, or hospitalization for unstable angina at 2 years.
DAIC
MAY 14, 2024
Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.
Journal of the American Heart Association
JANUARY 23, 2025
Hemodynamic reactivity, changes in endothelial function, and vasoconstriction during mental stress were evaluated using changes in ratepressure product, brachial artery flowmediated vasodilation, and peripheral arterial tonometry, respectively. A total of 629 participants were included.
Coronary Artery Disease Journal
OCTOBER 23, 2023
Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.
52 
Circulation: Cardiovascular Quality & Outcomes
NOVEMBER 20, 2024
We investigated whether PTSD was independently associated with first and recurrent heart failure hospitalizations in the setting of coronary artery disease.METHODS:Individuals with stable coronary artery disease and without heart failure at baseline were enrolled in 2 parallel prospective cohort studies in metropolitan Atlanta, GA.
Journal of Cardiovascular Pharmacology
NOVEMBER 11, 2024
Patients with ST-segment elevation myocardial infarction (STEMI) and complex coronary artery disease (CAD) face a poor prognosis, including increased heart failure (HF) risk. All three CAD complexity scores (SYNTAX, SYNTAX II and Gensini) were associated with an increased risk of adverse events (HR 1.02
Frontiers in Cardiovascular Medicine
OCTOBER 7, 2024
ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk. The in-hospital stroke rate was similar (LVAD 7 [5.4%] vs. CABG 8 [6.2%], p = 0.9). In-hospital survival, 1-year survival, and 3-year survival were 90.5%
Journal of the American Heart Association
MARCH 27, 2025
BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
Frontiers in Cardiovascular Medicine
OCTOBER 7, 2024
BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.
Open Heart
NOVEMBER 14, 2023
Background Out-of-hospital cardiac arrest (OHCA) has a dismal prognosis with overall survival around 10%. Previously, 80% of sudden cardiac arrest have been attributed to coronary artery disease. Survival curves were performed among hospitalised patients with acute myocardial infarction (AMI) as well as heart failure.
Open Heart
JUNE 21, 2022
Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.
Journal of the American Heart Association
DECEMBER 1, 2023
BackgroundCoronary computed tomography angiography is increasingly used as the first‐line test for suspected coronary artery disease. The overall mortality, cardiac deaths, myocardial infarctions, and hospitalizations for unstable angina were acquired from national registry data for 1 to 10 years of follow‐up (median, 4 years).
Frontiers in Cardiovascular Medicine
FEBRUARY 5, 2024
Background Kounis syndrome is an acute coronary syndrome (ACS) caused by allergic reactions, including coronary artery spasm (type I) caused by allergies without coronary predisposing factors, pre-existing coronary atherosclerosis, and coronary artery disease. ng/ml(0–0.5 ng/ml).
Circulation
NOVEMBER 11, 2024
Background:Myocardial infarction with nonobstructive coronary artery disease (MINOCA) is a special syndrome with clear evidence of myocardial ischemia, but no clear stenosis of coronary artery imaging sign. Circulation, Volume 150, Issue Suppl_1 , Page A4143007-A4143007, November 12, 2024.
DAIC
MARCH 13, 2024
There's growing sentiment that drug-coated balloons could address an unmet clinical need among patients with coronary artery disease in the United States.” Each year, millions of people around the world undergo coronary angioplasty, a non-surgical intervention to treat blockages in the arteries that supply blood to the heart.
116 
Coronary Artery Disease Journal
MAY 29, 2024
Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional risk factors such as serum iron levels. vs. 1.0%, P < 0.05) compared with the control group.
Coronary Artery Disease Journal
OCTOBER 31, 2023
Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2% Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2%
52 
Coronary Artery Disease Journal
JUNE 10, 2024
Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. In-hospital mortality was 73.6 ± 1.8%, but only 29.2 ± 1.9 The contemporary incidence, mortality, and management of post-STEMI VSR remains unclear.
Open Heart
JUNE 5, 2024
We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. Patients with coronary artery disease were excluded. Secondary outcomes included in-hospital and 30-day events. vs 9.9%, p=0.029).
DAIC
JANUARY 23, 2024
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Coronary Artery Disease Journal
APRIL 24, 2024
Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
In this study, we aimed to evaluate the prognostic value of ΔLVEF when acquired by SPECT G-MPI in patients with coronary artery disease (CAD) and a LVEFStress 0% and ΔLVEF ≤ 0%), and survival analyses were conducted.
DAIC
JANUARY 25, 2024
mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease.
110 
All About Cardiovascular System and Disorders
MAY 26, 2024
It is now well known that even if a coronary artery is opened well after a myocardial infarction, with good flow in the epicardial coronary arteries, there could be impaired myocardial perfusion. Minimal microvascular resistance is studied invasively using the index of microcirculatory resistance.
52 
Circulation: Cardiovascular Interventions
FEBRUARY 27, 2024
Patients are eligible for recruitment if they have severe left ventricular systolic dysfunction, extensive coronary artery disease, and are due to undergo complex percutaneous coronary intervention (to the left main stem with calcium modification or to a chronic total occlusion with a retrograde approach).
Dr. Smith's ECG Blog
NOVEMBER 15, 2023
Angiogram No obstructive epicardial coronary artery disease Cannot exclude non-ACS causes of troponin elevation including coronary vasospasm, stress cardiomyopathy, microvascular disease, etc. Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management [Internet].
Circulation
NOVEMBER 11, 2024
The outcome measure was peri-procedural complications defined as a composite of perioperative death, major bleeding, contrast nephropathy, myocardial infarction, ischemic stroke, and major amputation. A history of coronary artery disease was noted in 40.7% Notable comorbidities included diabetes mellitus at 60.6%
Dr. Smith's ECG Blog
NOVEMBER 22, 2023
He was treated for infection and DKA and admission to hospital was planned. Hyperacute T-wave in lead III, with reciprocal findings in aVL -- single lead OMI in the setting of multivessel disease. So the presence of an open artery does not tell you anything about the state of the artery at the time of the ECG.
118 Frontiers in Cardiovascular Medicine
JANUARY 9, 2025
BackgroundThe prognostic value of triglyceride-glucose (TyG) has been well described in patients with coronary artery disease (CAD). Hyperhomocysteinemia (HHcy) promotes insulin resistance and has also been regarded as a potential risk factor for cardiovascular disease.
Cardiology Update
APRIL 9, 2024
EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). Here is our curated list of the top sessions.
52 
Circulation: Cardiovascular Quality & Outcomes
FEBRUARY 3, 2025
Resource use consumption data were collected from all study participants and hospital cost data from US participants (n=1125) to estimate total medical costs. The primary and secondary economic outcomes were total costs at 12 months and at 45 days, respectively, from the US health care system perspective.
40 
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
BoardVitals - Cardiovascular
FEBRUARY 10, 2020
Takotsubo Cardiomyopathy is distinguished by overall systolic dysfunction of the left ventricle (LV), replicating that of a myocardial infarction (heart attack), but without angiographic evidence of coronary artery disease or a blockage. What is Takotsubo Cardiomyopathy?
Circulation
NOVEMBER 11, 2024
Introduction:Over 6 million patients (pts) present to US emergency departments annually with chest pain (CP), of which the majority are found to have no serious disease. Evaluation of these pts results in substantial costs for unnecessary hospitalization and extensive testing. Length of stay (LOS) in the CPU to discharge was 10.4
40 
The British Journal of Cardiology
APRIL 16, 2024
Intra-procedural data included access route, coronary anatomy, lesion complexity, number of stents deployed, door-to-balloon time for primary PCI, and any intra-procedural complications. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.
40 
Dr. Smith's ECG Blog
JULY 21, 2024
Troponin T peaked at 38,398 ng/L ( = a very large myocardial infarction, but not massive-- thanks to the pre-PCI spontaneous reperfusion, and rapid internvention!! ). The patient was extubated on Day-3 of the hospital stay. Nossen's discussion confirm multi-vessel disease , including 90-99% osteal stenosis of the LMCA.
131 
Coronary Artery Disease Journal
NOVEMBER 1, 2023
Methods We compared the baseline characteristics, in-hospital outcomes, and the 12-month and long-term clinical outcomes of two large prospective registries on SCAD and TTS. In-hospital events (43.3% TTS patients have a worse in-hospital, mid-term, and long-term prognosis with higher noncardiac mortality than SCAD patients.
52 
Dr. Smith's ECG Blog
AUGUST 9, 2019
At the bottom of the post, I have re-printed the section on aVR in my article on the ECG in ACS from the Canadian Journal of Cardiology: New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department Case 1. Updates on the Electrocardiogram in Acute Coronary Syndromes.
Dr. Anish Koka
MAY 16, 2023
Diamond and Forrester accomplished this by first establishing the prevalence of coronary artery disease based on how clinically likely patients with chest pain symptoms were found to have coronary disease based on a coronary angiogram. Thanks for reading Dr. Anish Koka's Newsletter! This happens.
52 
EMS 12-Lead
MARCH 19, 2023
He denied any known medical history, specifically: coronary artery disease, hypertension, dyslipidemia, diabetes, heart failure, myocardial infarction, or any prior PCI/stent. Vital signs were noted to be unremarkable with respect to any hypo-hypertensive crisis, hypoxia, etc. No appreciable skin pallor.
Dr. Smith's ECG Blog
NOVEMBER 30, 2022
Another ECG was recorded 5 minutes later just before arrival at the hospital: Similar The patient was transported to a nearby suburban hospital with PCI capabilities while my partner cared for her. Such cases are classified as MINOCA (Myocardial Infarction with Non-Obstructed Coronary Arteries).
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content